Related references
Note: Only part of the references are listed.Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
F. M. Ruemmele et al.
JOURNAL OF CROHNS & COLITIS (2014)
HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants
Graham A. Heap et al.
NATURE GENETICS (2014)
Pharmacogenetics of azathioprine in inflammatory bowel disease: A role for glutathione-S-transferase?
Gabriele Stocco et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
The role of thiopurine metabolite monitoring in inflammatory bowel disease
Lauren Beswick et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2014)
Letter: successful mercaptopurine therapy after azathioprine-related pancreatitis in patients with IBD
L. Beswick et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis
N. A. Kennedy et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Safety of Thiopurine Therapy in Inflammatory Bowel Disease: Long-term Follow-up Study of 3931 Patients
Maria Chaparro et al.
INFLAMMATORY BOWEL DISEASES (2013)
Are Thiopurines Always Contraindicated After Thiopurine-Induced Pancreatitis in Inflammatory Bowel Disease?
Oren D. Ledder et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2013)
Personalized Therapies in Pediatric Inflammatory and Autoimmune Diseases
Gabriele Stocco et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Gene Polymorphisms Involved in Manifestation of Leucopenia, Digestive Intolerance, and Pancreatitis in Azathioprine-Treated Patients
Katerina Wroblova et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions
Dan Turner et al.
INFLAMMATORY BOWEL DISEASES (2012)
Difficulties and possibilities with thiopurine therapy in inflammatory bowel disease-Proceedings of the first Thiopurine Task Force meeting
Dirk P. van Asseldonk et al.
DIGESTIVE AND LIVER DISEASE (2011)
Pediatric Modification of the Montreal Classification for Inflammatory Bowel Disease: The Paris Classification
Arie Levine et al.
INFLAMMATORY BOWEL DISEASES (2011)
Association Between Adverse Effects Under Azathioprine Therapy and Inosine Triphosphate Pyrophosphatase Activity in Patients With Chronic Inflammatory Bowel Disease
Maria Shipkova et al.
THERAPEUTIC DRUG MONITORING (2011)
Common misconceptions about 5-aminosalicylates and thiopurines in inflammatory bowel disease
Javier P. Gisbert et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Azathioprine or mercaptopurine-induced acute pancreatitis is not a disease-specific phenomenon
E. J. M. Van Geenen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis
F. Bermejo et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease
A. Ansari et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Thiopurine-S-methyltransferase genotype and the response to azathioprine in inflammatory bowel disease
G. Stocco et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Meta-analysis: inosine triphosphate pyrophosphatase polymorphisms and thiopurine toxicity in the treatment of inflammatory bowel disease
J. M. Van Dieren et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease
RB Gearry et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Increased incidence of azathioprine-induced pancreatitis in Crohn's disease compared with other diseases
RK Weersma et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency
S Sumi et al.
HUMAN GENETICS (2002)
Individualized therapy with azathioprine or 6-mercaptopurine by monitoring thiopurine methyl-transferase (TPMT) activity
JP Gisbert et al.
REVISTA CLINICA ESPANOLA (2002)
Relevance of thiopurine methyltransferase activity in inflammatory bowel disease patients maintained on low-dose azathioprine
S Campbell et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Share Paper
